Biosynth Expands Berlin Site with a New Commercial Bioconjugation Suite
July 3, 2025
The new suite extends GMP bioconjugate production for intermediates and active pharmaceutical ingredients from early clinical phase through to late clinical phases and commercial supply. Staad - Biosynth, a leading developer and supplier of critical raw materials and services for life sciences and diagnostics, is pleased to announce the opening of its expanded GMP bioconjugation [...]
July 3, 2025
Oncomine Dx Express Test on the Ion Torrent Genexus Dx Integrated Sequencer generates results in as little as 24 hours to support timely therapy decisions CARLSBAD, Calif.--Thermo Fisher Scientific, the world leader in serving science, today announced the U.S. Food and Drug Administration (FDA) has approved the Oncomine™ Dx Express Test on the Ion Torrent™ [...]
MGI Tech Hands with Lincoln University to Revolutionize New Zealand Viticulture with Genomics
July 3, 2025
Auckland, New Zealand - MGI Tech Co., Ltd. (“MGI”), a company dedicated to developing core tools and technologies that drive innovation in life sciences, has joined efforts with Lincoln University in Canterbury to address sustainable challenges in viticulture through advanced sequencing technology. The initiative aims to utilize genomics to breed better varieties of grapevines and hops that [...]
Optibrium Partners with TalTech on EU-Funded PhD Programme to Advance Sustainable Drug Discovery
July 2, 2025
The research will focus on developing faster and more accurate methods for predicting drug metabolism CAMBRIDGE, UK – Optibrium, a leading developer of software and AI solutions for molecular design, today announced its partnership with TalTech (Tallinn University of Technology) to co-supervise an EU-funded PhD position as part of the INNOCHEMBIO programme1. This research project [...]
Clinically Validated Collagenase and Neutral Protease Enzymes
July 2, 2025
Amsbio, in association with Nordmark Biochemicals, has expanded its range of Collagenase and Neutral Protease NB enzymes with GMP grade formats and protocols to support advanced tissue dissociation workflows for applications from research to clinical use. These enzymes, derived from Clostridium histolyticum, are critical raw materials for isolating viable cells from complex tissues - an [...]
July 2, 2025
Taicang, China – PerkinElmer officially inaugurated its expanded manufacturing and R&D facility in Taicang Suzhou, Jiangsu Province today. This milestone marks a significant advancement in the company’s “In China, For China – and Beyond” strategy, reinforcing its long-term commitment to the Chinese market. Situated in the heart of the Yangtze River Delta, the new state-of-the-art facility [...]
July 2, 2025
INNOptimizer is using latest Bayesian Optimization algorithms and a broad set of analytical tools to guide optimizations with minimum experimentation needed. Don't waste time and money with poor experimental design - use INNOptimizer™ to guide your experiments with state-of-the art Bayesian Optimization algorythms.”— Oliver May (GM Synsilico)GELEEN, LIMBURG, NETHERLANDS, July 2, 2025 /EINPresswire.com/ -- SynSilico, [...]
Sartorius completes acquisition of MatTek
July 2, 2025
The life science group Sartorius has successfully closed the acquisition of MatTek Corp, including Visikol Inc, from the Swedish BICO Group AB, as announced in April. The acquisition was completed on July 1, 2025, following the receipt of the required regulatory approval and the fulfillment of other customary closing conditions. With the integration of the [...]
Launch of Pre-clinical Nuclear Imaging System for Cancer and Neurological Research
July 2, 2025
Ann Arbor, MI — There is a growing demand from medical research institutions for high resolution, compact imaging tools to better study disease progression in areas such as cancer, cardiovascular and neurodegenerative diseases and to develop novel treatments including radiotherapies. The first systems from MH3D, US-based innovator in compact pre-clinical single photon emission computed tomography [...]
Wabtec Finalizes Acquisition of Evident’s Inspection Technologies Division
July 1, 2025
PITTSBURGH – Wabtec Corporation (NYSE: WAB) announced today that it completed the acquisition of Evident’s Inspection Technologies division (Inspection Technologies), formerly part of the Scientific Solutions Division of Olympus Corporation, a global leader in Non-Destructive Testing, Remote Visual Inspection and Analytical Instruments solutions for mission critical assets. This acquisition strengthens Wabtec’s Digital Intelligence business with [...]

